A study to evaluate pharmacokinetics, safety and tolerability of MEDI0382 in Renal Impairment participants

Trial Identifier: D5670C00008
Sponsor: MedImmune, LLC
NCTID:: NCT03235375
Start Date: October 2017
Primary Completion Date: April 2018
Condition: Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation
English Translation

Trial Locations

Country Location
Germany Berlin, Germany, 10117
Germany Kiel, Germany, 24105
Germany München, Germany, 81241
New Zealand Auckland, New Zealand, 1010
New Zealand Christchurch, New Zealand, 8011